The director of The McCasland Family Comprehensive Headache Center talked about findings from a study that explored the effect of eptinezumab treatment in a broader chronic migraine population. [WATCH TIME: 6 minutes]
Fawad Khan, MD, FACNS, FAHS
Advertisement
Director of the Ochsner Comprehensive Epilepsy Center.
Articles by Fawad Khan, MD, FACNS, FAHS
Advertisement
Latest Updated Articles
The Broader Impact of Eptinezumab for Chronic Migraine Management: Fawad Khan, MD, FACNS, FAHSPublished: June 17th 2024 | Updated: June 19th 2024
- The Broader Impact of Eptinezumab for Chronic Migraine Management: Fawad Khan, MD, FACNS, FAHS
Published: June 17th 2024 | Updated: June 19th 2024
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Action Update, November 2025: Approvals, Clearance, and Boxed Warning
2
FDA Accepts NDA for Low-Sodium Oxybate TRN-257 in Narcolepsy and Idiopathic Hypersomnia
3
Cell Therapy Deramiocel Meets Primary End Point in Phase 3 DMD Cardiomyopathy Trial
4
Understanding the Mechanism and Rationale of Azetukalner to Treat Focal Epilepsy: Christopher Kenney, MD, FAAN
5
